GLP-1 drugs show promise in curbing substance use disorders; new trial launched

A new clinical trial will test GLP-1 weight-loss drugs for their effect on substance use disorders, following promising early results. The study also examines impacts on criminal justice involvement, employment, and housing stability. This expands the potential therapeutic scope of GLP-1s beyond metabolic conditions, though efficacy remains unproven.